Logo

Katie Breitenbach and Viktor Novy

Jun 26, 2019

CureMatch said today that it has hired Katie Breitenbach as chief financial officer and Viktor Novy as chief technical officer. Breitenbach brings experience with venture-backed startups and preparation for initial public offerings the software and cloud-services industries. Novy is a former IT director at Human Longevity. CureMatch is a San Diego-based startup that provides artificial intelligence-driven oncology treatment analysis services, including clinical decision support.

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.